Hydrochloric Acid → HCID 178464318, compound
Reaction equation
[CH2:1]([N:3]([CH2:38][CH3:39])[C:4]([NH:6][C:7]1[C:8]([C:18]2[NH:22][C:21]3[CH:23]=[C:24]([O:28][CH2:29][CH2:30][CH2:31][N:32]4[CH2:37][CH2:36][CH2:35][CH2:34][CH2:33]4)[C:25]([F:27])=[CH:26][C:20]=3[N:19]=2)=[N:9][N:10](C2CCCCO2)[CH:11]=1)=[O:5])[CH3:2].[ClH:40]>O1CCOCC1>[ClH:40].[CH2:38]([N:3]([CH2:1][CH3:2])[C:4]([NH:6][C:7]1[C:8]([C:18]2[NH:22][C:21]3[CH:23]=[C:24]([O:28][CH2:29][CH2:30][CH2:31][N:32]4[CH2:37][CH2:36][CH2:35][CH2:34][CH2:33]4)[C:25]([F:27])=[CH:26][C:20]=3[N:19]=2)=[N:9][NH:10][CH:11]=1)=[O:5])[CH3:39]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
70 mg of 1,1-diethyl-3-[3-[5-fluoro-6-(3-piperidin-1-ylpropoxy)-1H-benzimidazol-2-yl]-1-(tetrahydropyran-2-yl)-1H-pyrazol-4-yl]urea are suspended in 3 mL of a 3N solution of HCl in dioxane. The medium is stirred at ambient temperature for 48 hours. The solvent is evaporated off under vacuum in a rotary evaporator. The reaction crude is purified by flash chromatography on a 4 g silica cartridge, eluent: 100/0 to 80/20 dichloromethane/methanol. The fractions containing the expected product are concentrated and the solid obtained is triturated in isopropyl ether. After filtration and rinsing of the solid, 26.2 mg of 1,1-diethyl-3-{3-[5-fluoro-6-(3-piperidin-1-ylpropoxy)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}urea hydrochloride are isolated in the form of a sand-colored solid. 1H NMR (400 MHz, DMSO-d6, δ in ppm) after addition of a drop of TFA-d1 (CF3COOD-d1): 1.15 (t, J=7.0 Hz, 6H); 1.39 (m, 1H); from 1.57 to 1.76 (m, 3H); 1.83 (m, 2H); 2.22 (m, 2H); 2.93 (m, 2H); 3.25 (m, 2H); 3.37 (q, J=7.0 Hz, 4H); 3.51 (m, 2H); 4.21 (t, J=6.0 Hz, 2H); 7.34 (d, J=7.5 Hz, 1H); 7.56 (d, J=11.0 Hz, 1H); 8.00 (s, 1H).
Workup
- customThe solvent is evaporated off under vacuum in a rotary evaporator
- customThe reaction crude
- customis purified by flash chromatography on a 4 g silica cartridge, eluent
- additionThe fractions containing the expected product
- concentrationare concentrated
- customthe solid obtained
- customis triturated in isopropyl ether
- filtrationAfter filtration
- washrinsing of the solid, 26.2 mg of 1,1-diethyl-3-{3-[5-fluoro-6-(3-piperidin-1-ylpropoxy)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}urea hydrochloride
- customare isolated in the form of a sand-colored solid
- addition1H NMR (400 MHz, DMSO-d6, δ in ppm) after addition of a drop of TFA-d1 (CF3COOD-d1)
Sources & evidence
- ORD record
- ord-c48981fd01884731afa4ab7741706d5d
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09126969B2
Reaction notes
Loading…